Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies I: CT and MRI
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 23, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Megan L Blackwell1, Christian T Farrar, Bruce Fischl
1Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA 02129, USA.mlb@nmr.mgh.harvard.edu
Luxol fast blue (LFB) enhances ex vivo human brain MRI contrast by targeting myelin. This novel contrast agent improves visualization of subtle brain structures and layers, aiding in detailed anatomical mapping.
Failed At:
2026-06-19T13:42:42.194361+00:00